CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Imagine you're a molecular biologist wanting to launch a project seeking treatments for a newly emerging disease. You know ...

Since the start of the SARS-CoV-2 pandemic, several variants of the virus have developed into Variants of Concern (VOCs), as classified by the World Health Organization (WHO). VOCs are virus variants ...

When the covid madness was imposed upon the world five years ago, the lockdown advocates claimed they were just “doing ...

SARS-CoV-2 ribonucleic acid was present at 84 anatomical sites in significantly greater amounts among respiratory tissues than other tissues. SARS-CoV-2 RNA levels among early cases, mid-cases ...

The results showed that both SARS-CoV and SARS-CoV-2 envelopes have a spherical morphology, with the structural proteins forming multiple string-like islands in the membrane and clusters between ...

Antibody responses to new SARS-CoV-2 variant infections and vaccinations are powerfully shaped by prior exposures to earlier SARS-CoV-2 vaccines, according to a new study from the Perelman School ...

In the SARS-CoV-2 Immunity and Reinfection Evaluation (SIREN) study, which involved a large cohort of asymptomatic health care workers who underwent polymerase-chain-reaction (PCR) testing every 2 ...

Sarbecoviruses—the group of coronaviruses that includes both SARS-CoV-1 and SARS-CoV-2—have long circulated in horseshoe bats across Western China and Southeast Asia.

One of the isolates, RmYN02 is remarkably similar to SARS-2 (93.3% overall). That part of the virus which specifies the enzymes required for replication showed an even greater similarity (97.2%).